NCT03792477 - A Bioequivalence Study of Testosterone Cypionate in Hypogonadal Males | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 19, 2019

Primary Completion Date

April 2, 2020

Study Completion Date

April 2, 2020

Conditions

Hypogonadism

Interventions

BIOLOGICAL

Test formulation

A single testosterone cypionate solution for injection (new formulation) 200 mg dose administered IM deep in the gluteal muscle (Test formulation).

BIOLOGICAL

Reference formulation

A single testosterone cypionate solution for injection (currently marketed formulation) 200 mg dose administered IM deep in the gluteal muscle (Reference formulation).

Trial Locations (2)

32720

Avail Clinical Research, DeLand

33136

Syneos Health, Miami